Memorial Regional Hospital is just the fourth facility in the United States to earn advanced accreditiation from the American College of Cardiology.

“The advanced certification wouldn’t be possible without the expertise of our physicians, team members, and the commitment to provide the highest quality patient and family-centered care to our patients.”

HOLLYWOOD, Fla. (PRWEB)
June 07, 2022

Memorial Regional Hospital recently entered elite company, becoming just the fourth hospital in the United States to earn Advanced Heart Failure Accreditation from the American College of Cardiology (ACC). The Hollywood-based facility, home to the Memorial Cardiac and Vascular Institute, exceeded an array of stringent criteria during an onsite review of the staff’s ability to evaluate, diagnose, and treat patients with heart failure.

Demonstrating its excellence through pre-hospital care, early stabilization, acute care, transitional care, clinical quality measures, and more, Memorial Regional was the only hospital in South Florida to earn the designation, joining facilities in Indiana (Lutheran Hospital), Georgia (Union General Hospital), and Tampa (AdventHealth).

“The advanced certification wouldn’t be possible without the expertise of our physicians, team members, and the commitment to provide the highest quality patient and family-centered care to our patients,” said Peter Powers, Memorial Regional Hospital CEO. “We’re proud to be recognized as the leading cardiac program in South Florida.”

There are fewer than 60 hospitals in the country that have received Heart Failure Accreditation from the ACC, with the aforementioned four the only ones from that group earning the advanced certification. Facilities must take part in a multi-faceted clinical process that involves completion of a gap analysis, examination of variances of care, development of an action plan, onsite review, and ongoing monitoring. Accredited hospitals have streamlined processes, implemented guidelines and standards, and adopted best practices that better educate patients, improve outcomes, and more effectively and efficiently control disease.

Heart failure is a chronic and progressive condition where the heart is unable to pump enough

blood to meet the body’s needs for blood and oxygen. Memorial was recognized for its evidence-based, protocol-driven, and systematic approach to managing the disease that reduces time to treatment and identifies and predicts high-risk patients while also reducing length-of-stay and hospital readmissions.

(About MRH):

Memorial Regional Hospital (MRH), the 797-bed flagship of the Memorial Healthcare System, has served patients and families since 1953. A Level 1 trauma center, its clinical expertise and advanced technology equip it to handle the most critical situations. The facility also features a wide variety of medical and surgical services, including a cardiac and vascular institute, cancer institute, neuroscience institute, family birthplace, women’s and behavioral health services. There were more than 220,000 patient encounters at MRH in fiscal year 2021.

(About ACC):

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health.

Share article on social media or email:

“The State of Maryland has always been a leader when it comes to quality reporting, and this initiative aligns with our goal of delivering the right health information to the right place at the right time.”

COLUMBIA, Md. (PRWEB)
June 07, 2022

The State of Maryland has partnered with CRISP, Maryland’s state-designated health information exchange (HIE), and Medisolv, a leader in quality management software, to become the first state in the country to successfully receive Electronic Clinical Quality Measure (eCQM) data from Maryland hospitals under a new quality reporting mandate.

eCQMs are standardized performance measures that track a hospital’s quality of care using data from the organization’s Electronic Health Record (EHR). Hospitals are required to submit eCQMs annually as part of the Centers for Medicare and Medicaid Service’s (CMS) Inpatient Quality Reporting (IQR) program and to The Joint Commission as part of its hospital accreditation.

Under the new State of Maryland initiative, hospitals are required to submit quality performance data on a quarterly basis via the Medisolv Submission Portal integrated with CRISP’s HIE portal. This will enable the state to evaluate hospital performance, identify statewide areas for improvement, and incorporate benchmarks into policy development in a timely and consistent manner. The information gained on hospital performance will also provide the opportunity for the Maryland Health Care Commission to expand its reporting and transparency to the public.

“The State of Maryland has always been a leader when it comes to quality reporting, and this initiative aligns with our goal of delivering the right health information to the right place at the right time,” said Dianne Feeney, Associate Director of Quality Initiatives for the Maryland Health Services Cost Review Commission. “We are proud to once again lead the way in this space, and we hope to see other states adopt this model of reporting, because it will ultimately lead to safer and more equitable, efficient, and effective care for our nation’s patients.”

In the pilot phase of the project, 35 hospitals successfully submitted eCQM data through the CRISP/Medisolv Submission Portal for the optional 2021 performance period. Starting July 15, 2022, all Maryland hospitals are expected to submit their 2022 performance period eCQM data on a quarterly schedule.

“For more than a decade, Medisolv has empowered healthcare organizations to electronically capture, improve and submit their quality data to CMS. Now, with this partnership, we have demonstrated that organizations other than the federal government can collect eCQM data to evaluate and advance the quality of care being delivered today,” said Zahid Butt, M.D., CEO of Medisolv. “We are honored to partner with CRISP and the State of Maryland to blaze new trails in statewide digital quality measures reporting as envisioned by CMS in its digital quality measures (dQM) roadmap for the nation.”

About Maryland Health Services Cost Review Commission

The Maryland Health Services Cost Review Commission (HSCRC) is an independent State agency with seven Commissioners appointed by the Governor. The commission is authorized to establish hospital rates for all Maryland hospitals to promote cost containment, access to care, equity, financial stability, and hospital accountability.

About Maryland Health Care Commission

The Maryland Health Care Commission is an independent regulatory agency whose mission is to plan for health system needs, promote informed decision-making, increase accountability, and improve access in a rapidly changing health care environment by providing timely and accurate information on availability, cost, and quality of services to policy makers, purchasers, providers, and the public. They maintain the Maryland Health Care Quality Reports website which is a consumer-friendly tool to help assist consumers in making informed health care decisions and to promote greater transparency and accountability among health care providers.

About CRISP

CRISP is a regional health information exchange (HIE) serving Maryland, the District of Columbia, West Virginia, and the surrounding regions. A non-profit organization advised by a wide range of stakeholders who are responsible for healthcare throughout the region, CRISP has been formally designated as Maryland’s statewide HIE by the Maryland Health Care Commission. HIEs allow clinical information to move electronically among disparate health information systems. For more information about CRISP, visit http://www.crisphealth.org.

Contact: Craig Behm

Maryland Executive Director

CRISP

(410) 872-0823

craig.behm@crisphealth.org

About Medisolv, Inc.

Medisolv is the leading healthcare quality data management company. Their all-in-one quality management solution, ENCOR, provides tools that help healthcare organizations with core measure abstraction, electronic measure capture in the hospital and ambulatory settings, data aggregation from multiple sources and submission to various reporting entities including CMS, TJC, other payers, state entities, and reporting organizations such as ACOs.

ENCOR is 2015 Cures Edition ONC certified for all ambulatory and hospital electronic clinical quality measures (eCQMs) and Medisolv is a 2022 CMS-approved MIPS Qualified Clinical Data Registry (QCDR).

For more information about Medisolv, visit http://www.medisolv.com.

Contact: Erin Heilman

Vice President, Marketing

Medisolv

(443) 264-4362

eheilman@medisolv.com

Share article on social media or email:

MCG Interoperability Experts to Speak at AHIP 2022

“In this presentation, we will be describing realized savings that health plans can achieve while working towards regulatory mandates like the pending CMS rule for prior authorization.” – Daniel Cawood, Product Manager of Interoperability Solutions, MCG Health

SEATTLE (PRWEB)
June 07, 2022

MCG Health, part of the Hearst Health network and an industry leader in technology-enabled evidence-based guidance, announces its Product Manager of Interoperability Solutions, Daniel Cawood, and Technical Product Manager of Platform & Payer Automation, Larry McEntire, will present with Director of Clinical Operations & Systems, Christopher Tarr of CareSource at the AHIP 2022 Conference, June 21-23, 2022 in Las Vegas, Nevada. This annual conference brings together leaders from health insurance provider organizations to network and learn from experts that are shaping the future of health care. Conference sessions cover community health improvement, healthcare technology, alternative payment models and value-based care, data analytics, and care management.

MCG and CareSource will present the session, “Reducing Administrative Burden in Admission Authorizations,” on Thursday, June 23, 2022, from 11:30 a.m. to 12:15 p.m. The healthcare industry has struggled with the authorization process for decades; CAQH’s Index from 2021 estimates that 35% of prior authorization requests in 2021 were submitted in a fully manual fashion (phone, fax, email, mail). This session will focus on a project between MCG and CareSource that automated manual authorization submissions and made emergent inpatient admission authorizations fully electronic. The speakers will explore the lessons learned from implementation and share feedback received from these early adopters, including the realized savings from both payers and providers.

“We are excited to present at the AHIP conference alongside leaders in healthcare technology,” explained Mr. Cawood. “In this presentation, we will be describing realized savings that health plans can achieve while working towards regulatory mandates like the pending CMS rule for prior authorization. We will show attendees how this mandate could be a great opportunity for their organization.”

Daniel Cawood oversees the product development for MCG’s interoperability solutions and connecting payers and providers for authorization processes. Mr. Cawood began his time at MCG overseeing the Indicia suite of solutions (provider market clinical decision support) and value-based care solutions.

Larry McEntire II oversees the product development for two of MCG’s solution groups: (1) Interoperability – connecting payers and providers to reduce the burden related to authorization processes; and (2) content platforms – software and services used to access MCG’s gold-standard clinical guidance.

Christopher Tarr oversees the Clinical Services Integration and Systems team at CareSource, an administrator of Medicare, Medicaid, and Marketplace plans. Prior to joining CareSource, he worked in various roles at a major Blues plan in California including medical management, clinical systems configuration, system automation, product development, and clinical support. Mr. Tarr has been instrumental in the active implementation of automation technology to increase workflow efficiency and accuracy in the healthcare system.

For those interested in attending the AHIP 2022, registration details and additional information can be found at: https://www.ahip.org/conferences/ahip-2022.

About MCG Health

MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG’s artificial intelligence and technology, infused with clinical expertise, enables its clients to prioritize and simplify their work. MCG’s world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK. Hearst also holds a minority interest in the precision medicine and oncology analytics company M2GEN. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

Share article on social media or email:

T.A.G. Medical’s Quintus HIP is equipped with URQ® technology, which delivers cooling rates of >80K/s and enables multi-stage heat treatments in a single, integrated furnace cycle.

“The Quintus press will serve us for the implants and minimal cutting tools production, where high material uniformity and good mechanical properties are required.” — Ran Weizman, T.A.G. Medical Executive Vice President

VASTERAS, Sweden (PRWEB)
June 07, 2022

The Quintus Technologies Hot Isostatic Press (HIP) recently delivered to Israel’s T.A.G. Medical Products Corporation Ltd. will ensure the production of implants and surgical tools with the optimal material properties required by the exacting environments in which they are used.

Rapidly ramping up to expand its product range and markets, T.A.G. Medical is widely acknowledged as a leader in the design and production of innovative, high-quality medical and dental solutions that improve surgical procedures.

“To increase production capacity, we invested in a new MIM (Metal Injection Molding) production line,” states Ran Weizman, T.A.G. Medical Executive Vice President. “The Quintus press will serve us for the implants and minimal cutting tools production, where high material uniformity and good mechanical properties are required.”

Advanced proprietary features such as High Pressure Heat Treatment™ (HPHT™) and Uniform Rapid Quenching (URQ®) enable the Quintus press model QIH 15L to produce finished MIM parts with maximum theoretical density, ductility, and fatigue resistance. Incorporating heat treatment and cooling in a single process, HPHT combines stress-relief annealing, HIP, high-temperature solution-annealing (SA), high pressure gas quenching (HPGQ), and subsequent ageing or precipitation hardening (PH) in one integrated furnace cycle.

The consolidation of multiple steps in the HIP allows several functions to be performed in a single location, with fewer pieces of equipment on the production line, a central consideration for the Israeli medical device company.

“All T.A.G. manufacturing processes, from A to Z, are done under one roof. Therefore, it is important for us to work with equipment that gives us this option,” Mr. Weizman comments.

With a new emphasis on disposable surgical instruments in the TAGMIM production chain, faster throughput and higher workpiece quality are also essential. The QIH 15L’s URQ capability achieves an impressive cooling rate of >80K/s while minimizing thermal distortion and non-uniform grain growth. The press’s furnace chamber has a diameter of 6.69 inches (170 mm) and a height of 11.4 inches (290 mm) and operates at a maximum pressure of 207 MPa (30,000 psi) and a maximum temperature of 2,552°F (1,400°C).

“Quintus is the global leader in HIP technology,” notes Mr. Weizman. “We visited their factory a few years ago and were impressed with the company’s professional team, customer center, and production lines. Accurate, well controlled, and user friendly—the Quintus press meets all the above requirements.”

“Our presses are designed to enhance efficiency and lower per-unit processing costs while saving space, energy, and infrastructure,” says Jan Söderström, CEO of Quintus Technologies. “These are important benefits for companies like T.A.G. Medical that are looking ahead to mass production of development-stage products and expansion of their OEM business. We are delighted to be working with T.A.G. as it continues to develop solutions that improve quality of life, reduce costs, minimize surgery times, and save lives.”

The press was installed in the T.A.G. facility in May 2022.

About Quintus Technologies

Quintus Technologies is the global leader in high pressure technology. The company designs, manufactures, installs, and supports high pressure systems in three main areas: densification of advanced materials; sheet metal forming; and high pressure processing for food and beverage innovation, safety, and shelf life. Quintus has delivered over 1,900 systems to customers within industries such as energy, medical implants, space, aerospace, automotive, and food processing. The company is headquartered in Västerås, Sweden, with a presence in 45 countries worldwide. For more information, visit http://www.quintustechnologies.com

About T.A.G. Medical Products Corporation Ltd.

From its origins as a metal machine shop more than seven decades ago, T.A.G. Medical Products began blazing the trail towards its current position as a leader in the manufacturing of surgical instruments in 1992. Today, the company employs more than 250 professionals focused on customer service, education, and innovation. With its emphasis on problem-solving, T.A.G. consistently pioneers in the revolutionary design, development, and production of breakthrough products that improve medical procedures, elevate the healthcare industry, and transform everyday lives. To learn more, go to http://www.tag-med.com

Share article on social media or email: